









Markets
/
Stocks
/
nasdaq-kavl
/

Kaival Brands Innovations Group Inc

KAVL

0.513USD

-0.026-4.77%

Close 11/04, 16:00（ET）Quotes delayed by 15 min

5.92MMarket Cap

LossP/E TTM



Kaival Brands Innovations Group Inc

0.513

-0.026-4.77%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Kaival Brands Innovations Group Inc

Currency: USD Updated: 2025-11-04

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Despite a weak stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Kaival Brands Innovations Group Inc's Score

Industry at a Glance

Industry Ranking

29 / 31

Overall Ranking

491 / 4616

Industry

Food & Drug Retailing

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 0 analysts

Current Rating

Target Price

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Kaival Brands Innovations Group Inc Highlights

StrengthsRisks

Kaival Brands Innovations Group, Inc. is engaged in the sale, marketing, and distribution of electronic nicotine delivery system (ENDS) products, also known as e-cigarettes, in a variety of favors. The Company’s primary product is the Bidi Stick as well as other products manufactured by its affiliate Bidi Vapor LLC (Bidi). It holds the worldwide right to market and distribute the Bidi Stick and certain other products manufactured by Bidi. Bidi Stick is a disposable, tamper resistant ENDS product made with medical-grade components, a battery and technology designed to deliver a consistent vaping experience for adult smokers 21 and over. It distributes products to wholesalers and retailers of ENDS products. BIDI Stick comes in a variety of flavor options for adult cigarette smokers. It does not manufacture any of the products it resells. Its patent portfolio consists of approximately 19 existing and 47 pending with technologies related to vaporization and inhalation technologies.

Growing

The company is in a growing phase, with the latest annual income totaling USD 6.89M.

Fairly Valued

The company’s latest PE is -0.85, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 132.57K shares, decreasing 42.68% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 11.09K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of -0.36.

Financial Health

Currency: USD Updated: 2025-11-04

The company's current financial score is 7.32, which is higher than the Food & Drug Retailing industry's average of 6.74. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 142.43K, representing a year-over-year decrease of 80.05%, while its net profit experienced a year-over-year decrease of 68.07%.

Score

Industry at a Glance

Previous score

7.32

Change



Financials

7.24

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.48

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.33

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.32

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.24

Key Metrics

Free cash flow

No Data

Kaival Brands Innovations Group Inc's Company Valuation

Currency: USD Updated: 2025-11-04

The company’s current valuation score is 6.94, which is lower than the Food & Drug Retailing industry's average of 7.30. Its current P/E ratio is -0.85, which is -72.70% below the recent high of -0.23 and -361.68% above the recent low of -3.93.

Score

Industry at a Glance

Previous score

6.94

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 29/31

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-04

There is no earnings forecast score for this company; the Food & Drug Retailing industry's average is 7.63.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

No Data

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-04

The company’s current price momentum score is 2.39, which is lower than the Food & Drug Retailing industry's average of 6.50. Sideways: Currently, the stock price is trading between the resistance level at 0.61 and the support level at 0.46, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

2.51

Change

-0.12

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(1)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.014

Sell

RSI(14)

38.953

Neutral

STOCH(KDJ)(9,3,3)

13.578

Oversold

ATR(14)

0.045

Low Volatility

CCI(14)

-173.780

Sell

Williams %R

94.099

Oversold

TRIX(12,20)

-0.061

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

0.549

Sell

MA10

0.578

Sell

MA20

0.592

Sell

MA50

0.634

Sell

MA100

0.604

Sell

MA200

0.669

Sell

Institutional Confidence

Currency: USD Updated: 2025-11-04

The company’s current institutional recognition score is 3.00, which is lower than the Food & Drug Retailing industry's average of 5.94. The latest institutional shareholding proportion is 1.14%, representing a quarter-over-quarter decrease of 97.84%. The largest institutional shareholder is The Vanguard, holding a total of 11.09K shares, representing 0.10% of shares outstanding, with 15.55% decrease in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Kaival Holdings, L.L.C

1.57M

-47.15%

Bidi Vapor LLC

1.40M

Morris (Eric)

770.00K

-0.78%

Thoenes (Mark L)

620.00K

-0.01%

Patel (Ketankumar)

520.00K

Modi (Ashesh)

520.00K

Worner (David)

520.00K

UBS Financial Services, Inc.

63.97K

-12.00%

Geode Capital Management, L.L.C.

41.90K

-1.36%

Two Sigma Investments, LP

13.21K

-42.78%

Risk Assessment

Currency: USD Updated: 2025-11-04

The company’s current risk assessment score is 1.32, which is lower than the Food & Drug Retailing industry's average of 5.33. The company's beta value is -1.21. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.